Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Good day, everyone, and welcome to the InspireMD Third Quarter ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

The safety and effectiveness of the Neuroguard IEP (Contego Medical)—a three-in-one carotid stent system with integrated ...

Here's a batch of fresh news and announcements from across Imperial.From a promising route to reducing brain injury risk in stent surgery, to a new ...

In the pioneering years of CAS, an attempt was made to implant balloon-expandable stents to open up the internal carotid artery (ICA ... the outcome of the CAS procedure in approximately 20 ...

It found that only 11% of patients receiving Dex developed cerebral hyperperfusion, compared to 38% in a placebo group. Only 3% of patients went on to develop cerebral hyperperfusion syndrome, ...

NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease (CAD) and prevention of stroke, today announced financial and operating results for the third ...

The prospective, multicenter ROADSTER 3 postapproval trial is evaluating the safety and effectiveness of transcarotid artery re ...

Virginia J. Howard, Ph.D., FAHA, distinguished professor at the University of Alabama at Birmingham (UAB) in Birmingham, Alabama, will receive this year’s Population Research Prize at the American ...

A stroke can happen suddenly and cause major changes in a person’s life right away. The disruption of blood flow to the brain ...